News Releases

Anixa Biosciences Congratulates Scientific Advisory Board Member Dr. H. Michael Shepard as a 2019 Lasker Award Honoree

September 16, 2019

Anixa Biosciences to Present at Two Upcoming Investor Conferences

August 26, 2019

Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek™ Prostate Cancer Study

July 29, 2019

Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology

July 24, 2019

Anixa Biosciences Announces U.S. Department of Veterans Affairs VA Maryland Health Care System Joins Cchek™ Prostate Cancer Study

July 22, 2019

Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology

July 17, 2019

Anixa Biosciences Highlights Recent Publication in The Journal of Experimental Medicine on Myeloid Derived Suppressor Cells

July 16, 2019

Anixa Biosciences to Present at the CYTO 2019 - 34th Congress of the International Society for Advancement of Cytometry

May 29, 2019

Anixa Biosciences to Present at the Sachs Associates 5th Annual Immuno-Oncology BD&L and Investment Forum

May 21, 2019

Anixa Biosciences Announces Completion of Cchek™ Analytical Verification at CLIA Laboratory

May 13, 2019

1
2
3
4
5
6
7
8
9
10
...13
Next »

Latest News & Events

Sep 16, 2019

Anixa Biosciences Congratulates Scientific Advisory Board Member Dr. H. Michael Shepard as a 2019 Lasker Award Honoree

Read More...

Aug 26, 2019

Anixa Biosciences to Present at Two Upcoming Investor Conferences

Read More...

Jul 29, 2019

Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek™ Prostate Cancer Study

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.